6 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18393269 | IMMUNOASSAYS AND ENGINEERED PROTEINS FOR MONITORING ANTIBODY TREATMENTS TO THE IMMUNE CHECKPOINT INHIBITORS PD1 AND PD-L1 | YANG, TIAN | 1674 | Non-Final OA | Dec 21, 2023 |
| 18320912 | COMPOSITIONS, METHODS AND/OR KITS COMPRISING A RECOMBINANT HUMAN CD38-EXTRACELLULAR DOMAIN | HADDAD, MAHER M | 1641 | Final Rejection | May 19, 2023 |
| 18144930 | Methods and Compositions for Treating Aging-Associated Impairments with TIMP-2 Recombinant Proteins | SULLIVAN, DENNIS JOHN | 1642 | Non-Final OA | May 09, 2023 |
| 18015317 | ANTI-HUMAN IMMUNODEFICIENCY VIRUS-1 ANTIBODIES AND METHODS FOR USES THEREOF | MARCSISIN, ELLEN JEAN | 1677 | Final Rejection | Jan 09, 2023 |
| 17448506 | DEVICE AND METHOD FOR DETECTING BLOOD GROUP ANTIGENS BY MEANS OF AN INCOMPLETE ANTIBODY | CHIN, CHRISTOPHER L | 1677 | Non-Final OA | Sep 22, 2021 |
| 16333382 | NOVEL MAMMALIAN EXPRESSED HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE PROTEIN ANTIGENS | AEDER, SEAN E | 1642 | Non-Final OA | Mar 14, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial